These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19924412)

  • 1. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.
    Oka K; Yakushiji T; Sato H; Hirai T; Yamashita Y; Mizuta H
    Skeletal Radiol; 2010 Feb; 39(2):141-6. PubMed ID: 19924412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
    Uhl M; Saueressig U; Koehler G; Kontny U; Niemeyer C; Reichardt W; Ilyasof K; Bley T; Langer M
    Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
    Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
    Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
    Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
    PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience.
    Asmar K; Saade C; Salman R; Saab R; Khoury NJ; Abboud M; Tamim H; Makki M; Naffaa L
    Eur J Radiol; 2020 Mar; 124():108855. PubMed ID: 32018075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.
    Baunin C; Schmidt G; Baumstarck K; Bouvier C; Gentet JC; Aschero A; Ruocco A; Bourlière B; Gorincour G; Desvignes C; Colavolpe N; Bollini G; Auqier P; Petit P
    Skeletal Radiol; 2012 Sep; 41(9):1141-9. PubMed ID: 22318350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
    Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
    Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
    Liu C; Xi Y; Li M; Jiao Q; Zhang H; Yang Q; Yao W
    Korean J Radiol; 2019 May; 20(5):801-811. PubMed ID: 30993931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
    Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
    J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
    Li X; Zhang K; Shi Y; Wang F; Meng X
    J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Diffusion-Weighted Imaging in Neoadjuvant Chemotherapy for Osteosarcoma: A Systematic Review and Meta-Analysis.
    Yuan W; Yu Q; Wang Z; Huang J; Wang J; Long L
    Acad Radiol; 2022 Feb; 29(2):326-334. PubMed ID: 33386220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of apparent diffusion coefficient values and diffusion-weighted magnetic resonance imaging in differentiation between benign and malignant thyroid nodules.
    Mutlu H; Sivrioglu AK; Sonmez G; Velioglu M; Sildiroglu HO; Basekim CC; Kizilkaya E
    Clin Imaging; 2012; 36(1):1-7. PubMed ID: 22226435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
    Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
    J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.
    Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
    Eur J Radiol; 2019 Oct; 119():108635. PubMed ID: 31445487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis.
    Agnello F; Ronot M; Valla DC; Sinkus R; Van Beers BE; Vilgrain V
    Radiology; 2012 Feb; 262(2):511-9. PubMed ID: 22143926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.
    Habre C; Dabadie A; Loundou AD; Banos JB; Desvignes C; Pico H; Aschero A; Colavolpe N; Seiler C; Bouvier C; Peltier E; Gentet JC; Baunin C; Auquier P; Petit P
    Pediatr Radiol; 2021 Aug; 51(9):1714-1723. PubMed ID: 33877417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.